Fifth Third Bancorp
PAVM icon

Fifth Third Bancorp’s PAVmed PAVM Stock Holding History

Fifth Third Bancorp’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-10
Closed -$6K – 2319
2018
Q3 		$6K Hold
10
– – ﹤0.01% 1950
2018
Q2 		$4K Hold
10
– – ﹤0.01% 2092
2018
Q1 		$7K Buy
+10
New +$8.57K ﹤0.01% 1989

Other funds holding PAVM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GWS
Glassman Wealth Services Vienna, Virginia $736M AUM 17.99% 1-Year Est. Return

Fifth Third Bancorp's PAVM Position: Q4 2018 in Review

Fifth Third Bancorp sold out of PAVmed (PAVM) in Q4 2018, closing a stake of 10 shares — an estimated $6K sold.

Fifth Third Bancorp first reported a position in PAVM in Q1 2018 and held it in 3 quarters. The position peaked at $7K in Q1 2018. 7 funds tracked by Wall St. Rank hold PAVM as of Q4 2018.

  • Fifth Third Bancorp reported no remaining PAVmed position as of Q4 2018 after selling out during the quarter.
  • Fifth Third Bancorp sold 10 PAVmed shares in Q4 2018, an estimated $6K.
  • Fifth Third Bancorp first reported a position in PAVmed in Q1 2018 and held it in 3 quarters.
  • Fifth Third Bancorp's PAVmed position peaked at $7K in Q1 2018.
  • 7 funds tracked by Wall St. Rank held PAVmed as of Q4 2018.

Based on Fifth Third Bancorp's 13F filing for Q4 2018, filed 14 Feb 2019.